Novavax, Inc. (NVAX)
6.66
-0.12
(-1.77%)
USD |
NASDAQ |
Dec 09, 16:00
6.69
+0.03
(+0.45%)
After-Hours: 05:56
Novavax Total Assets (Quarterly): 1.180B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc. | 208.73B |
| Moderna, Inc. | 12.14B |
| Merck & Co., Inc. | 129.55B |
| Sangamo Therapeutics, Inc. | 88.64M |
| Arcturus Therapeutics Holdings, Inc. | 282.34M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.337B |
| Shareholders Equity (Quarterly) | -156.67M |
| Debt to Equity Ratio | -1.603 |
| Current Ratio | 2.267 |
| Net Debt Paydown Yield | -0.25% |